Tag: WHO

  • WHO Secretariat Accuses Tobacco Industry of Interference

    WHO Secretariat Accuses Tobacco Industry of Interference

    The Secretariat of the WHO Framework Convention on Tobacco Control (FCTC) accused the tobacco industry of ramping up efforts to interfere with international tobacco control policymaking in advance of the Conference of the Parties (COP11) beginning November 17 in Geneva, according to the Albanian Daily News (ADN). Andrew Black, acting head of the WHO FCTC Secretariat, condemned what he described as deliberate attempts to weaken global health measures.

    “With strategies varying from lobbying to outright attempts to manipulate delegations, the tobacco industry’s tactics are a cause for serious concern,” Black was quoted by the ADN. “This is not just lobbying; it is a deliberate strategy to try to derail consensus and weaken measures to further the treaty’s implementation. Tobacco industry interference is one of the biggest constraints and barriers to the implementation of the Convention. The Secretariat strongly urges Parties, civil society, and other stakeholders working to support tobacco control to remain vigilant against the industry’s tactics and misinformation.”

    The COP11 session will bring together representatives from across the globe to discuss new policies to curb nicotine addiction, protect human health, and address environmental harms linked to tobacco.

  • UK Set to Miss 2030 Smoke-Free Target, New Analysis Finds

    UK Set to Miss 2030 Smoke-Free Target, New Analysis Finds

    A new analysis by Haypp, in collaboration with Swedish economist David Sundén, shows that the UK is unlikely to achieve its goal of being smoke-free by 2030 if current trends continue. Based on smoking rate declines across the UK and EU, England is projected to reach smoke-free status in 2032, Wales in 2033, Scotland in 2034, and Northern Ireland not until 2037. The study defines smoke-free as having less than 5% of the population smoking daily, in line with the World Health Organization criteria.

    The report highlights Sweden as a global leader, set to become smoke-free on October 25, 2025, driven by high cigarette taxes and widespread access to alternatives like snus and nicotine pouches. In comparison, the UK’s overall daily smoking rate remains at 11.9%, with rates among young adults (18–24) at 9.8%. Sweden’s young-adult smoking rate is 2.3%.

    Sundén notes that while alternatives such as vapes have helped reduce smoking, the rate of decline is slowing and some regions have even seen slight increases over the past year.

    The analysis also points to the potential public health impact if the UK adopted Sweden’s harm reduction strategies. Markus Lindblad, Haypp’s Director of External Affairs, emphasized that the UK has an opportunity to follow Sweden’s approach, using alternative nicotine products to accelerate the transition away from combustible tobacco as Parliament considers the Tobacco and Vapes Bill.

  • TPA Brief Criticizes WHO Tobacco Treaty for Ignoring Evidence

    TPA Brief Criticizes WHO Tobacco Treaty for Ignoring Evidence

    The Taxpayers Protection Alliance (TPA) released a new policy brief today (October 20), “FCTC: The Wrong Lessons Learned,” by Roger Bate, a fellow at the International Center for Law and Economics, criticizing the World Health Organization’s Framework Convention on Tobacco Control (FCTC) for drifting from its original mission of evidence-based policy. The paper argues that the treaty’s decision-making process has become obscured, ideological, and resistant to scientific debate—particularly around harm reduction products such as e-cigarettes and oral nicotine.

    “The FCTC has evolved into a closed process—hostile to scientific dissent, opaque in its deliberations, and resistant to consumer-driven innovation in tobacco harm reduction (THR),” the paper begins. “This paper argues that the FCTC has become a cautionary model for global public-health governance. Unless checked, this model risks entrenching an authoritarian and anti-scientific impulse across public health. The THR community must lead the counter-narrative—to reform tobacco control and safeguard the integrity of evidence-based policymaking.”

    Bate contends that the FCTC’s approach “demonizes safer alternatives despite real-world success,” preventing adult smokers from accessing less harmful products that could help them quit. He warns that the treaty’s governance flaws mirror broader problems in global health governance, including pandemic response. “A treaty built to reduce smoking deaths should evaluate tools by outcomes, not ideology,” he said.

    The brief calls for reforms, including open sessions at FCTC Conferences of the Parties (COPs), equal conflict-of-interest scrutiny, independent comparisons of cessation tools, proportionate youth protections, and fiscal accountability. TPA fellow Martin Cullip urged the WHO to “reassess the evidence on reduced-risk nicotine products” and improve transparency, warning that the FCTC’s current direction “has become an obstacle to global public health progress.”

  • WHO Facing Crises of Relevance, Former Director Says

    WHO Facing Crises of Relevance, Former Director Says

    Dr. Tikki Pang, a professor and former Director of Research Policy and Cooperation at the World Health Organization (WHO), delivered a compelling keynote at the Global Tobacco and Nicotine Forum (GTNF) in Brussels, urging the global public health community to “find a detour” around entrenched opposition to tobacco harm reduction (THR). Drawing a vivid analogy, Pang said the WHO’s position acts like a “landslide blocking the road” to progress, creating ripple effects that influence policy, weaken public trust, and stigmatize innovation. Attempts to change this stance, he said, have proven “frustrating and futile.”

    “‘Tobacco control’ has become the complete elimination of tobacco in society,” Pang said. “It’s become pretty much ideological at this point. It has become evidence-selective, perhaps evidence-blind.

    “We need to overcome this perception that the industry is the cause of the problem and not part of the solution.’

    Pang described the journey toward a THR-friendly world as “a long road with many obstacles,” and warned that the EU’s recent alignment with anti-THR policies could have “global repercussions.” Instead, he called for a “circuit breaker” — independent, multi-stakeholder platforms that operate outside the WHO’s Conference of the Parties (COP) framework. These coalitions should unite industry, consumers, investors, media, and advocates to advance harm reduction directly, he said.

    Pang emphasized the crucial role of media and advocacy in countering misinformation, noting that journalists can either “spread misconceptions or become powerful allies.” He also suggested situating THR within the broader context of non-communicable disease (NCD) prevention.

    Reflecting on his 13 years at the WHO, Pang acknowledged its achievements in supporting underserved populations but said the organization now faces “a crisis of relevance and confidence.” He concluded that while the WHO’s mission explicitly includes improving global health — including for smokers seeking better alternatives — progress will depend on using science-driven innovation and rational policy to achieve that goal.

    “Science has given us the tools to reduce harm from tobacco,” Pang said. “Reason dictates that we should use them.”

  • BAT’s Wheaton Calls for Policymakers to Embrace Harm Reduction at GTNF Opening

    BAT’s Wheaton Calls for Policymakers to Embrace Harm Reduction at GTNF Opening

    Brussels, October 6, 2025 — Kingsley Wheaton, Chief Corporate Officer of BAT, opened the Global Tobacco and Nicotine Forum (GTNF) with a call for policymakers to embrace harm reduction and real-world evidence as the basis for future regulation.

    “Right now, we stand at a crossroads,” Wheaton said. “One where the choices we make — as individuals, as companies, and as an industry — will shape the future of public health, policy, and perception.”

    Speaking under the GTNF’s theme, “Real World Evidence: The Race to Reduce Harm,” Wheaton argued that Sweden’s near smoke-free status demonstrates the effectiveness of tobacco harm reduction. He credited awareness campaigns, consumer access to smokeless products, and progressive regulation for driving smoking rates to among Europe’s lowest.

    “Sweden is on the verge of achieving something extraordinary: a smoking rate of just 5.3%—less than a quarter of the EU average,” he said. “This isn’t just a number. It’s a public health milestone. And it’s a powerful validation of a strategy that many dismissed: harm reduction.

    “Despite decades of global anti-smoking campaigns, 1 billion people still smoke. At BAT, we believe quitting is the best choice any smoker can make. But for those who won’t quit, offering scientifically substantiated, reduced-risk alternatives is essential. Sweden proves this approach works.”

    In his remarks, Wheaton touted the success of BAT’s Omni program, the company’s global platform and manifesto for tobacco harm reduction launched in 2024. He said Omni is both a movement and a communications framework through which BAT promotes its vision of a “Smokeless World,” aiming to make smokeless products mainstream and push for regulatory environments that support harm reduction.

    “With Omni, we’re launching a platform for science, dialogue, and collaboration to accelerate progress toward a smokeless world,” Wheaton said. “This transformation took belief—belief that we could be part of the solution. And today, I’m proud to say: we were right to believe in it.

    Wheaton also criticized prohibitionist policies, pointing to Australia’s illicit market as evidence of unintended consequences when safer alternatives are restricted. He urged EU policymakers to adopt proportionate, risk-based regulation that recognizes harm reduction as part of tobacco control.

    “How can policymakers not see what’s right in front of their eyes?” Wheaton said. “When safer alternatives are blocked, the void is filled by danger, not progress. It’s time to rethink, recalibrate, and reclaim the narrative. So perhaps it’s time to ask: What if the most effective way to end smoking isn’t to fight nicotine, but to reimagine it? What if the companies that once sold cigarettes can now lead the charge to make them obsolete?

    “The WHO continues to ignore and sideline harm reduction, clinging to outdated dogma while real-world evidence piles up. This is not just intransigence, it’s negligence. It’s time for policymakers to stop pretending this evidence doesn’t exist. Seventy percent of policy experts still believe nicotine is the primary cause of smoking-related diseases, like cancer. That’s not just inaccurate, it’s dangerous. If we’re serious about closing the Tobacco Harm Reduction deficit, we must engage directly with regulators, health authorities, and policy experts to ensure that safer alternatives are not just available, but understood, accepted, and encouraged.”

    The GTNF is the world’s leading annual conference discussing the future of the tobacco and nicotine industries. It is the global exchange for views and ideas between public health experts, government representatives, the industry, and investors.

  • What Role Does the FCTC Play in Today’s Regulatory Environment?

    What Role Does the FCTC Play in Today’s Regulatory Environment?

    At the Global Tobacco and Nicotine Forum (GTNF) in Brussels, an expert panel explored the growing disconnect between the World Health Organization’s Framework Convention on Tobacco Control (FCTC) and real-world tobacco harm reduction (THR) progress. The session featured Dr. Derek Yach, global health advocate and former WHO executive; Peter Beckett, Co-Founder of Clearing the Air; Dr. Tikki Pang, a professor and former WHO Director of Research Policy and Cooperation; and Dr. Christopher Snowdon, Head of Lifestyle Economics at the Institute of Economic Affairs.

    Yach opened the discussion by criticizing the gap between FCTC policymaking and on-the-ground data. He noted that smoking rates are falling faster in countries embracing harm reduction — such as the U.S., U.K., Japan, South Korea, and New Zealand — than under traditional tobacco control strategies. “If it can happen in Pakistan, it can happen in all of Southeast Asia,” he said. “And if it happens in Southeast Asia, we could be seeing oral cancer in the rearview mirror.” Yach emphasized the need for collaborative public–private partnerships to ensure product safety and credibility, while urging policymakers to move beyond what he called the “distraction” of youth-related arguments that ignore the millions of adult smokers seeking alternatives.

    “It’s not that youth use isn’t important, but putting all the attention on kids doesn’t help for 50 years,” he said. “What about their parents? We could be adding years to their lives right now. [Anti-THR people] just use the youth as a way to divide the argument. We need to shift to the data and take the kid issue off the table.”

    Beckett took a blunt tone, arguing that the FCTC framework is obsolete, exclusive, and lacking transparency. He said the WHO’s current approach alienates the public and damages its credibility, calling the situation “chaotic,” which makes it easier for harm-reduction advocates to push back on. Beckett urged reform-minded countries — especially WHO funders — to “recognize the world as it is” and resist “bullying by overpaid foundations with an agenda,” and accused prohibitionist groups of crossing the line.

    “Ten years ago, they were disingenuous; now they’re straight-up lying,” he said. “I keep hearing the same damn thing. ‘We need to engage with science, we need to be nice to the other side.’ I’m calling bullshit on that. It doesn’t work. There is no amount of science that will do the job. If there was, they’d let me in the bloody room when they have these conversations. We have to recognize this and say enough, and call for a tearing down of the framework in its entirety, because it’s not salvageable.”

    Pang reiterated that many developing countries adopt WHO guidance without generating or analyzing their own data. “They take the easy way out,” he said, “because they lack the capacity to build evidence locally.” Pang pointed to emerging “pockets of positive thinking” among countries that are now re-evaluating WHO recommendations and embracing THR. He called for greater industry unity — across state-owned, multinational, and startup sectors — and stronger alignment with consumer voices. “Consumers are also voters,” he reminded the audience, “and together they can influence policy.”

    Snowdon warned of troubling developments within the WHO, citing “endgame” proposals that reject harm reduction as an industry “con.” He described this as a “quasi-religious mission to destroy all tobacco,” resistant to evidence and reason. Snowdon noted that while grassroots THR advocacy exists, it ironically remains underfunded and overshadowed by well-resourced opposition.

    “We are greatly out-financed. The industry can contribute, but then we get ostracized,” he said. “We have a genuine grassroots movement, but these people have lives to live. They can’t be doing it all the time. Meanwhile, the other side has unlimited resources. The media could be helpful, but they don’t want to risk it.”

    Across the panel, a consensus emerged: the WHO’s FCTC framework risks irrelevance unless it adapts to include harm reduction. Participants agreed that the future of global health policy must be driven by data, innovation, and collaboration rather than ideology.

    The GTNF is the world’s leading annual conference discussing the future of the tobacco and nicotine industries. It is the global exchange for views and ideas between public health experts, government representatives, the industry, and investors.

  • NYT Claims Industry Influence Weakened WHO Declaration

    The New York Times published an article yesterday (September 24) highlighting how the World Health Organization’s final declaration on chronic diseases has been weakened compared to earlier drafts, and attributes those changes to corporate lobbying from tobacco, alcohol, and beverage companies.

    “Gone was the language calling for graphic health warnings on cigarette packs,” the article says. “Gone, too, were the recommendations for so-called health taxes to discourage smoking and the consumption of alcohol and sugar-sweetened drinks. The final document contains no mention of sugary beverages, a key culprit in the rising rates of childhood obesity that affects 35 million children under 5 years old.”

    Catherine Egbe, a senior scientist at the South African Medical Research Council, attributes the removal of plain packaging and graphic health warnings is due partly to industry opposition.

    When the language is strong and watertight, it helps countries do better,” she said. “But when the language is weak, it sends the message that ‘you can do what you want’ and leaves vulnerable populations at the mercy of industry.”

  • CAPHRA Slams WHO Over Barriers to COP11 Participation

    CAPHRA Slams WHO Over Barriers to COP11 Participation

    The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) criticized the World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC) for imposing what it calls “insane” registration requirements for the upcoming COP11 in Geneva. Executive Coordinator Nancy Loucas said the late opening of registration, coupled with onerous demands for personal documentation, a letter of intent, a full CV, and a declaration of zero tobacco funding, is deliberately designed to exclude consumer advocacy groups and harm reduction voices. Despite the FCTC being in place for two decades, not a single consumer group has ever been granted observer status, while only 26 NGOs have been approved overall, far fewer than in comparable UN forums such as climate negotiations.

    CAPHRA said the WHO’s restrictive interpretation of Article 5.3 has been weaponized to silence stakeholders, including people who smoke or use safer nicotine products. Proceedings remain closed to the media and the public, with no live streaming or meaningful transparency, a practice Loucas calls fundamentally undemocratic. CAPHRA is urging reform to allow full and fair participation, stressing that genuine tobacco harm reduction requires including the very consumers most affected by global policy decisions.

  • WHO Report Links Tobacco Use to Child Stunting

    WHO Report Links Tobacco Use to Child Stunting

    The World Health Organization (WHO) published a new report warning that tobacco use plays a significant role in child stunting, a condition that affects nearly 150 million children worldwide, particularly in Africa and Asia. Stunting increases the risk of disease, delayed development, and early death. The document, the 11th in WHO’s tobacco knowledge summary series, is aimed at health professionals, policymakers, and public health advocates.

    WHO said that maternal smoking during pregnancy is strongly linked to preterm birth, low birth weight, and restricted fetal growth, all major predictors of stunting by age 2. Children exposed to second-hand smoke are also at higher risk, it said, with evidence showing that the harm intensifies with the level of exposure. By contrast, quitting smoking during pregnancy improves growth outcomes, reducing the risk of stunting.

    The organization is urging governments to strengthen tobacco control policies in line with the WHO Framework Convention on Tobacco Control (FCTC) and MPOWER measures. WHO stressed that reducing tobacco exposure is critical to improving survival, growth, and development, and to achieving global health goals.

  • CAPHRA Challenges WHO’s Tobacco Control Approach

    CAPHRA Challenges WHO’s Tobacco Control Approach

    A new Shadow Report from the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) criticizes the World Health Organization’s (WHO) global tobacco control strategy for neglecting harm reduction — a key component of the WHO’s own Framework Convention on Tobacco Control (FCTC). CAPHRA’s report argues that countries strictly following WHO’s MPOWER measures, like Thailand and India, have seen only limited declines in smoking, while nations adopting harm reduction tools, such as vaping, have achieved greater success. It cites the UK, Japan, New Zealand, and Canada as leading examples.

    With over 1 billion smokers worldwide, CAPHRA calls for “practical, science-based solutions” to replace abstinence-only approaches. The group also condemns the exclusion of harm reduction advocates from policy discussions under FCTC Article 5.3.

    “This is a call to action,” the report states. “We must replace moralistic dogma with practical solutions. It is time to make smoking — the deadliest form of tobacco use — public enemy No. 1, and to deploy harm reduction as a frontline strategy.”